Inventor
BOYD L. HARRISON
Inventor
US
Overview
Patents· 37 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Jprimary
C07JSteroids40%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations32%
A61KPreparations for medical, dental or toiletry purposes25%
C07BGeneral methods of organic chemistry2%
C07DHeterocyclic compounds1%
PatentTitleYear
12,540,157Oxysterols and methods of use thereof202612,473,327Neuroactive steroids, compositions and uses thereof202512,448,409Oxysterols and methods of use thereof202512,421,275Compositions and methods for treating CNS disorders202512,331,070C7 substituted oxysterols and methods of use thereof202512,201,64019-nor C3,3-disubstituted C21-n-pyrazolyl steroids and methods of use thereof202512,180,247Oxysterols and methods of use thereof202412,180,248Compositions and methods for treating CNS disorders202412,129,275Neuroactive steroids, compositions, and uses thereof202412,129,276Oxysterols and methods of use thereof202412,071,453Neuroactive steroids, compositions, and uses thereof202412,065,463Compositions and methods for treating CNS disorders202411,993,628C7, C12, and C16 substituted neuroactive steroids and their methods of use202411,945,836Compositions and methods for treating CNS disorders202411,926,646C7 substituted oxysterols and methods of use thereof202411,912,73719-nor neuroactive steroids and methods of use thereof202411,905,309Neuroactive steroids and methods of use thereof202411,884,697Oxysterols and methods of use thereof202411,878,995Oxysterols and methods of use thereof202411,851,457Oxysterols and methods of use thereof202311,780,875Neuroactive steroids, compositions, and uses thereof202311,732,000Oxysterols and methods of use thereof202311,718,642Compositions and methods for treating CNS disorders202311,613,556Oxysterols and methods of use thereof202311,542,297Compositions and methods for treating CNS disorders202311,530,237Compositions and methods for treating CNS disorders202211,498,940Neuroactive steroids, compositions, and uses thereof202211,407,782Oxysterols and methods of use thereof202211,396,525C17, C20, and C21 substituted neuroactive steroids and their methods of use202211,344,56319-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereof202211,279,730Oxysterols and methods of use thereof202211,261,21119-NOR neuroactive steroids and methods of use thereof202211,241,44619-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereof202211,149,057Neuroactive steroids, compositions, and uses thereof202111,149,056C7 substituted oxysterols and methods of use thereof202111,149,054Oxysterols and methods of use thereof202111,147,877Compositions and methods for treating CNS disorders2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2025Patents assigned to SAGE THERAPEUTICS INC (36)· patent assignee history
2021–2026Based in US· patent location history
2023Patents assigned to SAGE THERAPEUTICS (1)· patent assignee history
2024Patents assigned to SAGE THERPEUTICS INC (1)· patent assignee history
2025Patents assigned to SAGE THERAPEUTICS LLP (1)· patent assignee history
2026Patents assigned to SAGE THERAPEUTICS LLC (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| SAGE THERAPEUTICS INC | 36 | 2021–2025 |
| SAGE THERAPEUTICS | 1 | 2023 |
| SAGE THERAPEUTICS LLC | 1 | 2026 |
| SAGE THERAPEUTICS LLP | 1 | 2025 |
| SAGE THERPEUTICS INC | 1 | 2024 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 37 | 2021–2026 |